CA 125 with HAMA Treatment

The CA 125 with HAMA Treatment test contains 1 test with 1 biomarker.

CA 125 is used as an aid in monitoring the response to therapy for patients with epithelian ovarian cancer and in detecting residual ovarian cancer in patients who have undergone therapy. HAMA pre-treatment inhibits possible heterophilic interference.

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Ca 125, Hama Treated